Molecular Genetics Unit, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Área de Genética, Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Tenerife, Spain.
Am J Respir Cell Mol Biol. 2020 Oct;63(4):444-451. doi: 10.1165/rcmb.2020-0021OC.
Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized by reduced levels of serum AAT due to mutations in the (Serpin family A member 1) gene. The PiS (Glu264Val) is one of the most frequent deficient alleles of AATD, showing high incidence in the Iberian Peninsula. Herein, we describe two new alleles carrying an S mutation but producing a null phenotype: QO and QO. The new alleles were identified by sequencing the gene in three patients who had lower AAT serum levels than expected for the initial genotype. These alleles are the result of combined mutations in a PIS allele. Sequencing detected the S mutation with Tyr138Cys (S+Tyr138Cys) in two patients, whereas a third one had the S mutation with Pro391Thr variant (S+Pro391Thr). When expressed in a cellular model, these variants caused strong AAT polymerization and very low AAT secretion to almost undetectable levels. The isoelectric focusing method for plasma AAT phenotyping did not show AAT protein encoded by the novel mutant alleles, behaving as null. We called these alleles PIS-plus because the S variant was phased with another variant conferring more aggressive characteristics to the allele. The current data demonstrate that the clinical variability observed in AATD can be explained by additional genetic variation, such as dual -acting variants in the gene. The possible existence of other unrevealed variants combined in the PIS alleles should be considered to improve the genetic diagnosis of the patients.
α1-抗胰蛋白酶缺乏症(AATD)是一种遗传性疾病,其特征是由于 (丝氨酸蛋白酶家族 A 成员 1)基因中的突变导致血清 AAT 水平降低。PiS(Glu264Val)是 AATD 最常见的缺陷等位基因之一,在伊比利亚半岛发病率较高。在此,我们描述了两个新的等位基因,它们携带 S 突变但表现为无效表型:QO 和 QO。通过对三个血清 AAT 水平低于初始基因型预期的患者的 基因进行测序,发现了这两个新等位基因。这些等位基因是在一个 PIS 等位基因中发生的组合突变的结果。测序在两个患者中检测到 S 突变与 Tyr138Cys(S+Tyr138Cys),而第三个患者则发生了 S 突变与 Pro391Thr 变体(S+Pro391Thr)。当在细胞模型中表达时,这些变体导致强烈的 AAT 聚合和极低的 AAT 分泌,几乎无法检测到。用于鉴定血浆 AAT 表型的等电聚焦方法没有显示出由新突变等位基因编码的 AAT 蛋白,表现为无效。我们称这些等位基因为 PIS-plus,因为 S 变体与另一个赋予等位基因更具侵袭性特征的变体相结合。目前的数据表明,AATD 中观察到的临床变异性可以通过其他遗传变异来解释,例如 基因中的双重作用变体。应该考虑到 PIS 等位基因中可能存在其他未被揭示的变体组合,以改善对患者的遗传诊断。